Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study.

J Bradley Layton Mary E RitcheyZhongwen HuangShailesh ChavanHakan AyNizar Souayah Colin Anderson-Smits

Published in: Neurology and therapy (2023)

A heavy burden of symptoms, comorbidities, and diagnostic testing exists in patients with CIDP initiating IVIG. Characteristics of patients with CIDP initiating different IVIG products are well balanced, suggesting an absence of clinical or demographic determinants underlying IVIG selection.

Keyphrases

health insurance
high dose
oxidative stress
risk factors
low dose
depressive symptoms
sleep quality